Makoto Kinoshita

机构：Fukuoka Institute of Health and Environmental Sciences, University of Tokyo Hospital, The University of Tokyo · ORCID：0000-0001-7012-6782

发表论文 118 篇 · 总被引 4788 次 · h-index 34

代表论文

• Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study (2023 · The Lancet Neurology · 被引 276)
• Single-cell transcriptome landscape of circulating CD4+ T cell populations in autoimmune diseases (2024 · Cell Genomics · 被引 61)
• Reconstruction of the personal information from human genome reads in gut metagenome sequencing data (2023 · Nature Microbiology · 被引 50)
• Clinical practice guidelines for multiple sclerosis, neuromyelitis optica spectrum disorder, and myelin oligodendrocyte glycoprotein antibody-associated disease 2023 in Japan (2024 · Multiple Sclerosis and Related Disorders · 被引 24)
• Impact of Vutrisiran on Quality of Life and Physical Function in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy (2023 · Neurology and Therapy · 被引 21)
• Spatial transcriptomics elucidates medulla niche supporting germinal center response in myasthenia gravis-associated thymoma (2024 · Cell Reports · 被引 19)